Ensysce Biosciences, Inc.ENSC
Price (close)
$0.41
Market cap
—
P/E
—
Revenue (TTM)
$4.5M
Net income
-$12.6M
Dividend yield
—
1-year total return
-81.8%
Net margin
-280.5%
Revenue growth
-39.3%
Debt / equity
—
What Ensysce Biosciences, Inc. does.
were originally incorporated in the State of Delaware in April 2003 as PharmacoFore, Inc. and, in January 2012, we changed our name from
mailing address of our principal executive office is 7946 Ivanhoe Avenue, Suite 201, La Jolla, California 92037. Our corporate telephone
number is (858) 263-4196. Our website address is www.ensysce.com. Information contained on our website, or connected thereto, does not
Revenue and profit, by fiscal year.
| Fiscal year | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | $3.9M | $3.5M | $2.5M | $2.2M | $5.2M | $5.1M |
| Net income | $4.3M | -$29.1M | -$24.2M | -$10.6M | -$8.0M | -$10.2M |
| Free cash flow | — | — | — | — | — | -$7.9M |
More on ENSC.
- Ensysce Biosciences, Inc. summary
- Ensysce Biosciences, Inc. financial statements
- Ensysce Biosciences, Inc. key metrics
- Ensysce Biosciences, Inc. health scores and style box
- Ensysce Biosciences, Inc. earnings
- Ensysce Biosciences, Inc. dividends
- Ensysce Biosciences, Inc. valuation
- Ensysce Biosciences, Inc. ownership and insiders
- Ensysce Biosciences, Inc. peers
Figures from Ensysce Biosciences, Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.